Aim 2: Determine the mechanisms by which HMs mediate activation of PAD2, with citrullination of vimentin in lung macrophages (LM’s) using a novel, selective pharmacologic inhibitor of PAD2 (AFM30a) as ...
It has been known for many decades that uremic bleeding and platelet dysfunction put patients at increased risk of general bleeding. The exact mechanism by which the risk is increased remains ...